Santen Pharmaceutical , Ltd. Profit Margin

Santen Pharmaceutical , Ltd.'s profit margin stands at 13.26% as of June 2026. That compares with 10.72% in the prior-year period — up 23.8% year over year. That is above the sector sector average of 13.23%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Santen Pharmaceutical , Ltd. reported 13.26% in profit margin versus 10.72% a year earlier — a 23.8% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Santen Pharmaceutical , Ltd. sits higher the its sector benchmark (13.23%) with a profit margin of 13.26%. That is roughly 0.3% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 13.26% for Santen Pharmaceutical , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Santen Pharmaceutical , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places 4536.T next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.